Status:
UNKNOWN
Prospective Two-arm Study of Fertility in Men With COVID-19
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Covid19
Fertility Issues
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
COVID-19 infection is hypothesized to have a potentially negative effect on male fertility through direct damage to the testes. The current trial is aimed at investigating the effect of SARS-CoV-2 on ...
Detailed Description
In late December 2019, the Chinese city of Wuhan witnessed the emergence of a form of pneumonia of unknown etiology. By the middle of January 2020, the disease had managed to spread beyond the country...
Eligibility Criteria
Inclusion
- Clinical or imaging signs of COVID-19 infection
- Nasopharyngeal swab positive for SARS-CoV2 mRNA
Exclusion
- Inability to collect semen for analysis
- Congenital anomalies of the testes
- Varicocele
- A history of fertility disorders
Key Trial Info
Start Date :
January 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04716179
Start Date
January 18 2021
End Date
August 31 2021
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sechenov University.
Moscow, Russia, 119991